References
- Salazar EL, Torres JA, Avila A, et al. Hyperplastic changes and receptor status in the breast tissue of bodybuilders under anabolic-androgenic steroid simulation. Arch Androl 2000;45:1–7
- Salazar EL, Paredes A, Moreno E, et al. Hormone receptors and cellular differentiation: relationship/ expression in breast carcinoma. Adv Reprod 1998; 2:71–7
- Iwai K, Fukuda K, Hachisuga T, et al. Prognostic significance of progesterone receptor immuno-histochemistry for lymph node metastases in endometrial carcinoma. Gynecol Oncol 1999;72: 351–9
- Shiohara S, Shiozawa T, Shimizu M, et al. Histo chemical analysis of estrogen and progest-erone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis. Cancer 1997;80:908–16
- Henderson BE, Ross RK, Pike MC. Toward the primary prevention of cancer. Science 1991;254: 1131–8
- Schneider J, Huh MM, Bradlow HL, Fishman J. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem 1984;259:4840–5
- Fishman J, Martucci C. Biological properties of 16 alpha-hydroxyestrone: implications in estrogen physiology and pathophysiology. J Clin Endocrinol Metab 1980;51:611–15
- Bucala R, Fishman J, Cerami A. Formation of covalent adducts between cortisol and 16 alpha-hydroxyestrone and protein: possible role in the pathogenesis of co rtisol toxicity and systemic lupus erythematosus. Proc Natl Acad Sci USA 1982; 79:3320–4
- Swaneck GE, Fishman J. Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc Natl Acad Sci USA 1988;85:7831–5
- Miyairi S, Ichikawa T, Nambara T. Structure ofthe adduct of 16a-hydroxyestrone with a primary amine: evidence for the Heyns rearrangement of steroidal D-ring 16a-hydroxyimines. Steroids 1991;56: 361–6
- Lustig RH, Mobbs CV, Pfaff DW, et al. Temporal actions of 16 alpha-hydroxyestrone in the rat: comparisons oflordosis dynamics with other estro-gen metabolites and between sexes. J Steroid Biochem Mol Biol 1989;33:417–21
- Salazar EL, Sojo AT, Lopez R, et al. The evidence of an etiological relationship between oral contra-ceptive use and dysplastic change in cervical tissue. Gynecol Endocrinol 2001;15:23–8
- Nandi S, Guzman RC, Yang J. Hormones and mammary carcinogenesis in mice, rats and humans: a unifying hypothesis. Proc Natl Acad Sci USA 1995;92:3650–7
- Ethier SP. Growth factor synthesis and human breast cancer progression. J Natl Cancer Inst 1995; 87:964–73
- Liehr JG. Mechanism of metabolic activation and inactivation of catecholestrogens: a basis of geno-toxicity. Polycycl Arom Comp 1994;6:229–39
- Li Y, Trush MA, Yager JD. DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol of estradiol. Carcinogenesis 1995;15: 1421–7
- Davis DL, Bradlow HL, Wolff M, et al. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 1993; 101:372–7
- Telang NT, Suto A, Wong GY, et al. Introduction by estrogen metabolite 16a-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst 1992;84:634–8
- van Dijk MA, Hart AA, van't Veer IT Differences in estrogen receptor a variant messenger RNAs between normal human breast tissue and primary breast carcinomas. Cancer Res 2000;60:530–3
- Mitrani-Rosenbaum S, Tsveli R, Tur-Kaspa R. Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells. J Gen Virol 1989;70: 227–32
- Porias H, Carranco LA, Sojo AT, et al. Hormonal content of plasma and endometrium of women taking oral contraception. Obstet Gynecol 1978; 52:703–2
- Elson DA, Riley RR, Lacey A, et al. Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis. Cancer Res 2000; 60:1267–75
- Bradlow HL, Hershcopf RJ, Martucci CP, et al. Estradiol 16a-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc Natl Acad Sci USA 1985; 82:6295–9
- Auborn KJ, Woodworth C, DiPaolo JA, et al. The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis. Int J Cancer 1991;49:867–9
- Newfield L, Bradlow HL, Sepkovic DW, et al. Estrogen metabolism and the malignant potential of human papillomavirus immortalized keratino-cytes. Proc Soc Exp Biol Med 1998;217:322–6